Incyte Corporation (INCY): Price and Financial Metrics
Incyte Corporation (INCY)
Today's Latest Price: $87.76 USD
Updated Oct 19 9:50pm
Add INCY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
INCY Stock Summary
- INCY has a market capitalization of $19,820,698,074 -- more than approximately 90.31% of US stocks.
- Of note is the ratio of Incyte Corp's sales and general administrative expense to its total operating expenses; only 9.46% of US stocks have a lower such ratio.
- For INCY, its debt to operating expenses ratio is greater than that reported by merely 5.85% of US equities we're observing.
- If you're looking for stocks that are quantitatively similar to Incyte Corp, a group of peers worth examining would be BNTX, MGNX, MCRB, NTLA, and XENE.
- Visit INCY's SEC page to see the company's official filings. To visit the company's web site, go to www.incyte.com.
INCY Stock Price Chart Interactive Chart >
INCY Price/Volume Stats
| Current price | $87.76 | 52-week high | $110.36 |
| Prev. close | $90.63 | 52-week low | $62.48 |
| Day low | $86.90 | Volume | 1,037,300 |
| Day high | $91.29 | Avg. volume | 1,605,645 |
| 50-day MA | $91.92 | Dividend yield | N/A |
| 200-day MA | $89.83 | Market Cap | 19.19B |
Incyte Corporation (INCY) Company Bio
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.
Loading social stream, please wait...